Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hutchinson, KS
NPI
1700014255
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2101 N Waldron St
Hutchinson, KS, 67502
Phone (620) 669-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
21,947 services
Medicare patients, 2024
1,323
Average age 71
Drug cost, 2024
$3.2M
9,481 prescriptions
Company payments, 2025
$1,368
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremiah R Kempke was code 36415 (venipuncture blood collection), 1,480 times for 762 patients. In total Jeremiah R Kempke billed 21,947 services in 56 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,480 | 762 | $8.62 | $13K |
| 99214 Office E&M - Established | Office | 1,347 | 976 | $82.41 | $111K |
| 84443 Clinical Chemistry | Office | 988 | 602 | $16.41 | $16K |
| 83036 Blood Count | Office | 793 | 380 | $9.51 | $7,541 |
| 84439 Clinical Chemistry | Office | 708 | 401 | $8.81 | $6,235 |
| 80048 Clinical Chemistry | Office | 507 | 308 | $8.29 | $4,203 |
| 95251 Test - Miscellaneous | Office | 384 | 288 | $23.90 | $9,178 |
| 80053 Clinical Chemistry | Office | 359 | 233 | $10.33 | $3,708 |
| 99204 Office E&M - New | Office | 240 | 240 | $106.60 | $26K |
| 85025 Blood Count | Office | 132 | 86 | $7.56 | $998 |
| 83970 Clinical Chemistry | Office | 107 | 77 | $40.19 | $4,300 |
| 84480 Clinical Chemistry | Office | 99 | 70 | $13.76 | $1,362 |
| 82570 Clinical Chemistry | Office | 73 | 71 | $5.08 | $371 |
| 80061 Clinical Chemistry | Office | 70 | 65 | $13.12 | $918 |
| 82306 Clinical Chemistry | Office | 69 | 60 | $28.72 | $1,981 |
By year: 2022 $204K for 21,971 services; 2023 $213K for 26,247 services; 2024 $215K for 21,947 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,480 | 762 | $8.62 | $13K |
| 84443 Clinical Chemistry | 988 | 602 | $16.41 | $16K |
| 83036 Blood Count | 793 | 380 | $9.51 | $7,541 |
| 84439 Clinical Chemistry | 708 | 401 | $8.81 | $6,235 |
| 80048 Clinical Chemistry | 507 | 308 | $8.29 | $4,203 |
| 80053 Clinical Chemistry | 359 | 233 | $10.33 | $3,708 |
| 85025 Blood Count | 132 | 86 | $7.56 | $998 |
| 83970 Clinical Chemistry | 107 | 77 | $40.19 | $4,300 |
| 84480 Clinical Chemistry | 99 | 70 | $13.76 | $1,362 |
| 82570 Clinical Chemistry | 73 | 71 | $5.08 | $371 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeremiah R Kempke prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,249 prescriptions and refills. In total Jeremiah R Kempke wrote 9,481 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,249 | 2,350 | 294 | $8,606 |
| Ozempic Semaglutide | 457 | 568 | 97 | $532K |
| Methimazole Generic | 416 | 718 | 102 | $2,893 |
| Metformin Hcl Er Metformin Hcl | 291 | 675 | 85 | $1,911 |
| Pioglitazone Hcl Generic | 287 | 637 | 62 | $2,331 |
| Novolog Flexpen Insulin Aspart | 287 | 404 | 92 | $80K |
| Liothyronine Sodium Generic | 280 | 467 | 76 | $7,453 |
| Mounjaro Tirzepatide | 275 | 308 | 57 | $316K |
| Trulicity Dulaglutide | 268 | 289 | 51 | $273K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 266 | 450 | 73 | $42K |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 245 | 336 | 71 | $230K |
| Glimepiride Generic | 241 | 525 | 59 | $1,470 |
| Jardiance Empagliflozin | 236 | 322 | 39 | $180K |
| Metformin Hcl Generic | 231 | 503 | 55 | $1,418 |
| Tresiba Flextouch U-200 Insulin Degludec | 212 | 324 | 50 | $244K |
Brand drugs: 4,894 claims; generic drugs: 3,855 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremiah R Kempke $1,368 ($1,368 in general payments such as food, travel and fees) from 21 companies. The largest payer was Insulet Corporation with $312.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 37 | $312 |
| Abbvie Inc. ABBV | 12 | $149 |
| Tandem Diabetes Care, Inc. TNDM | 7 | $95.19 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $95.18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $90.28 |
| Corcept Therapeutics CORT | 4 | $82.07 |
| Abbott Laboratories ABT | 4 | $73.09 |
| Lilly USA, LLC LLY | 4 | $61.15 |
| Novo Nordisk Inc NVO | 3 | $57.39 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $49.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.